Thermo Fisher Scientific Inc. (TMO) stock
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3035% above fair value
$699.44−18.27 (-2.55%)
Close on Nov 12, 2026Market cap $259.15BP/E 36.9Yield 0.25%
Thermo Fisher Scientific EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Thermo Fisher Scientific's EPS for the twelve months ending Sep 26, 2026 was $18.95, up 9.5% year over year. For fiscal 2025 it was $17.74, up 7.3% from the year before. Over ten years it grew 13.7% a year on average. The highest annual figure on record is $19.46 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.74 | +7.3% |
| FY2024 | Dec 31, 2024 | $16.53 | +7.0% |
| FY2023 | Dec 31, 2023 | $15.45 | -12.4% |
| FY2022 | Dec 31, 2022 | $17.63 | -9.4% |
| FY2021 | Dec 31, 2021 | $19.46 | +21.9% |
| FY2020 | Dec 31, 2020 | $15.96 | +74.0% |
| FY2019 | Dec 31, 2019 | $9.17 | +26.7% |
| FY2018 | Dec 31, 2018 | $7.24 | +29.5% |
| FY2017 | Dec 31, 2017 | $5.59 | +9.8% |
| FY2016 | Dec 31, 2016 | $5.09 | +3.5% |
| FY2015 | Dec 31, 2015 | $4.92 | +4.5% |
| FY2014 | Dec 31, 2014 | $4.71 | +35.3% |
| FY2013 | Dec 31, 2013 | $3.48 | +8.4% |
| FY2012 | Dec 31, 2012 | $3.21 | -7.2% |
| FY2011 | Dec 31, 2011 | $3.46 | +36.8% |
| FY2010 | Dec 31, 2010 | $2.53 | +25.9% |
| FY2009 | Dec 31, 2009 | $2.01 | -10.7% |
| FY2008 | Dec 31, 2008 | $2.25 | +33.1% |
| FY2007 | Dec 31, 2007 | $1.69 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $4.64 | +8.7% |
| Q2 FY2026 | Jun 27, 2026 | $4.68 | +9.3% |
| Q1 FY2026 | Mar 28, 2026 | $4.43 | +11.3% |
| Q4 FY2025 | Dec 31, 2025 | $5.20 | +8.8% |
| Q3 FY2025 | Sep 27, 2025 | $4.27 | +0.5% |
| Q2 FY2025 | Jun 28, 2025 | $4.28 | +5.9% |
| Q1 FY2025 | Mar 29, 2025 | $3.98 | +15.0% |
| Q4 FY2024 | Dec 31, 2024 | $4.78 | +13.8% |
| Q3 FY2024 | Sep 28, 2024 | $4.25 | -3.8% |
| Q2 FY2024 | Jun 29, 2024 | $4.04 | +15.1% |
| Q1 FY2024 | Mar 30, 2024 | $3.46 | +4.2% |
| Q4 FY2023 | Dec 31, 2023 | $4.20 | +4.2% |
| Q3 FY2023 | Sep 30, 2023 | $4.42 | +16.6% |
| Q2 FY2023 | Jul 1, 2023 | $3.51 | -16.8% |
| Q1 FY2023 | Apr 1, 2023 | $3.32 | -40.8% |
| Q4 FY2022 | Dec 31, 2022 | $4.03 | -3.6% |
| Q3 FY2022 | Oct 1, 2022 | $3.79 | -20.9% |
| Q2 FY2022 | Jul 2, 2022 | $4.22 | -8.5% |
| Q1 FY2022 | Apr 2, 2022 | $5.61 | -4.6% |
| Q4 FY2021 | Dec 31, 2021 | $4.18 | -33.2% |
| Q3 FY2021 | Oct 2, 2021 | $4.79 | -1.0% |
| Q2 FY2021 | Jul 3, 2021 | $4.61 | +59.0% |
| Q1 FY2021 | Apr 3, 2021 | $5.88 | +198.5% |
| Q4 FY2020 | Dec 31, 2020 | $6.26 | +151.4% |
| Q3 FY2020 | Sep 26, 2020 | $4.84 | +157.4% |
| Q2 FY2020 | Jun 27, 2020 | $2.90 | +4.7% |
| Q1 FY2020 | Mar 28, 2020 | $1.97 | -2.5% |
| Q4 FY2019 | Dec 31, 2019 | $2.49 | +12.2% |
| Q3 FY2019 | Sep 28, 2019 | $1.88 | +7.4% |
| Q2 FY2019 | Jun 29, 2019 | $2.77 | +49.7% |
| Q1 FY2019 | Mar 30, 2019 | $2.02 | +41.3% |
| Q4 FY2018 | Dec 31, 2018 | $2.22 | +70.8% |
| Q3 FY2018 | Sep 29, 2018 | $1.75 | +30.6% |
| Q2 FY2018 | Jun 30, 2018 | $1.85 | +18.6% |
| Q1 FY2018 | Mar 31, 2018 | $1.43 | +2.1% |
| Q4 FY2017 | Dec 31, 2017 | $1.30 | -18.2% |
| Q3 FY2017 | Sep 30, 2017 | $1.34 | – |
| Q2 FY2017 | Jul 1, 2017 | $1.56 | – |
| Q1 FY2017 | Apr 1, 2017 | $1.40 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.59 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?